Goat Anti-Human Kappa-HRP 抗體 | 貨號2060-05

Goat Anti-Human Kappa-HRP 抗體

產品介紹: Southernbiotch提供Goat Anti-Human Kappa-HRP 高品質多株抗體，免疫源為 Pooled antisera from goats hyperimmunized with human κ light chains。特異性Reacts with human κ light chains。Isotype為Goat IgG。抗體純化後具有HRP標誌。抗體溶液為50% glycerol/50% PBS, pH 7.4。可應用於ELISA、FLISA、Flow Cytometry 、ELISpot 、Immunohistochemistry-Paraffin Sections、Immunocytochemistry 、Western Blot、Immunoprecipitation、Surface Plasmon Resonanc等實驗。貯存於2-8°C。

ELISA plate was coated with purified human IgGκ, IgMκ, IgAκ, IgGλ, IgMλ, and IgAλ. Immunoglobulins were detected with serially diluted Goat Anti-Human Kappa-HRP (SB Cat. No. 2060-05).

Specificity	Reacts with human κ light chains
Source	Pooled antisera from goats hyperimmunized with human κ light chains
Cross Adsorption	Human λ light chains; may react with κ light chains from other species
Purification	Affinity chromatography on human κ light chains covalently linked to agarose
Isotype	Goat IgG
Format/Conjugate	HRP (Horseradish Peroxidase)
Buffer Formulation	50% Glycerol/50% Phosphate buffered saline, pH 7.4
Volume	1.0 mL
Storage & Handling	2-8°C Please refer to product specific SDS
Applications	Quality tested applications for relevant formats include – ELISA 1-9 FLISA Flow Cytometry 19-22 Other referenced applications for relevant formats include – ELISpot 10 Immunohistochemistry-Paraffin Sections 11 Immunocytochemistry 12 Western Blot 4,13-17 Immunoprecipitation 18 Surface Plasmon Resonance 23 Purification 24 Stimulation 25
Recommended Dilutions	Please refer to product specific Technical Bulletin

細胞免疫專家極力推薦SouthernBiotech高品質抗體

美國抗體生產商Southern Biotech於1982年，由UAB細胞免疫專家Dr. Max Cooper與實驗室成員共同創立。SouthernBiotech致力於生產高品質抗體。物種種類齊全，包括有Bovine、Canine、Chicken、Cynomolgus、Donkey、Equine、Feline、Goat、Guinea Pig、Hamster、Human、Monkey、Mouse、Porcine、Rabbit、Rat、Rhesus、Sheep、Turkey。具有螢光物質（FITC、PE、APC、SPRD、PE/CY5.5、APC/CY5.5、Spectral Red、Alexa 488、Alexa 647、Pacific Blue）各種螢光標誌、另具酵素（HRP、AP）、或未標誌及Low Endotoxin/Azide Free（LE/AF）等標定。

引用文獻References

1. Pancook JD, Beuerlein G, Pecht G, Tang Y, Nie Y, Wu H, et al. In vitro affinity maturation of human IgM antibodies reactive with tumor-associated antigens. Hybrid Hybridomics. 2001;20:383-96. (ELISA)
2. Akamatsu Y, Pakabunto K, Xu Z, Zhang Y, Tsurushita N. Whole IgG surface display on mammalian cells: Application to isolation of neutralizing chicken monoclonal anti-IL-12 antibodies. J Immunol Methods. 2007;327:40-52. (ELISA)
3. Guan Y, Sajadi MM, Kamin-Lewis R, Fouts TR, Dimitrov A, Zhang Z, et al. Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection. Proc Natl Acad Sci USA. 2009;106:3952-7. (ELISA)
4. Lai H, Engle M, Fuchs A, Keller T, Johnson S, Gorlatov S, et al. Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice. Proc Natl Acad Sci USA. 2010;107:2419-24. (ELISA, WB)
5. Boross P, Lohse S, Nederend M, Jansen JH, van Tetering G, Dechant M, et al. IgA EGFR antibodies mediate tumour killing in vivo. EMBO Mol Med. 2013;5:1213-26. (ELISA)
6. Kehoe JW, Whitaker B, Bethea D, Lacy ER, Boakye K, Santulli-Marotto S, et al. Isolation and optimization for affinity and biophysical characteristics of anti-CCL17 antibodies from the VH1-69 germline gene. Protein Eng Des Sel. 2014;27:199-206. (ELISA)
7. Wyrzucki A, Dreyfus C, Kohler I, Steck M, Wilson IA, Hangartner L. Alternative recognition of the conserved stem epitope in influenza A virus hemagglutinin by a VH3-30-encoded heterosubtypic antibody. J Virol. 2014;88:7083-92. (ELISA)
8. Nagano R, Masuda K. Establishment of a signal peptide with cross-species compatibility for functional antibody expression in both Escherichia coli and Chinese hamster ovary cells. Biochem Biophys Res Commun. 2014;447:655-9. (ELISA)
9. London AS, Mackay K, Lihon M, He Y. Gel filtration chromatography as a method for removing bacterial endotoxin from antibody preparations. Biotechnol Prog. 2014;30:1497-1501. (ELISA)
10. Saletti G, Çuburu N, Yang JS, Dey A, Czerkinsky C. Enzyme-linked immunospot assays for direct ex vivo measurement of vaccine-induced human humoral immune responses in blood. Nat Protoc. 2013;8:1073-87. (ELISPOT)
11. Bonda DJ, Webber KM, Siedlak SL, Perry G, Friedland RP, Smith MA. The pathology of Alzheimer disease elicits an in vivo immunological response. Am J Immunol. 2007;3:10-14. (IHC-PS)
12. Campana D, Farrant J, Inamdar N, Webster AD, Janossy G. Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia. J Immunol. 1990;145:1675-80. (ICC)
13. Singh G, Parker S, Hobart P. The development of a bicistronic plasmid DNA vaccine for B-cell lymphoma. Vaccine. 2002;20:1400-11. (WB)
14. Corisdeo S, Wang B. Functional expression and display of an antibody Fab fragment in Escherichia coli: study of vector designs and culture conditions. Protein Expr Purif. 2004;34:270-9. (WB)
15. Phoolcharoen W, Bhoo SH, Lai H, Ma J, Arntzen CJ, Chen Q, et al. Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana. Plant Biotechnol J. 2011;9:807-16. (WB)
16. He J, Peng L, Lai H, Hurtado J, Stahnke J, Chen Q. A plant-produced antigen elicits potent immune responses against West Nile virus in mice. Biomed Res Int. 2014;2014:952865. (WB)
17. Helman D, Toister-Achituv M, Bar-Shimon M, Cohen B, Otmi I, Berger N, et al. Novel membrane-bound reporter molecule for sorting high producer cells by flow cytometry. Cytometry A. 2014;85:162-8. (WB)
18. Santiago T, Kulemzin SV, Reshetnikova ES, Chikaev NA, Volkova OY, Mechetina LV, et al. FCRLA is a resident endoplasmic reticulum protein that associates with intracellular Igs, IgM, IgG and IgA. Int Immunol. 2011;23:43-53. (IP)
19. Minegishi Y, Conley ME. Negative selection at the pre-BCR checkpoint elicited by human μ heavy chains with unusual CDR3 regions. Immunity. 2001;14:631-41. (FC)
20. Hinton PR, Xiong JM, Johlfs MG, Tang MT, Keller S, Tsurushita N. An engineered human IgG1 antibody with longer serum half-life. J Immunol. 2006;176:346-56. (FC)
21. Dong J, Sereno A, Aivazian D, Langley E, Miller BR, Snyder WB, et al. A stable IgG-like bispecific antibody targeting the epidermal growth factor receptor and the type I insulin-like growth factor receptor demonstrates superior anti-tumor activity. mAbs. 2011;3:273-88. (FC)
22. Xiang Y, Park S, Garrard WT. A major deletion in the V-J intervening region results in hyperelevated transcription of proximal V genes and a severely restricted repertoire. J Immunol. 2014;193:3746-54. (FC)
23. Wagner K, Kwakkenbos MJ, Claassen YB, Maijoor K, Böhne M, van der Sluijs KF, et al. Bispecific antibody generated with sortase and click chemistry has broad antiinfluenza virus activity. Proc Natl Acad Sci USA. 2014;111:16820-5. (Surface Plasmon Resonance)
24. Damschroder MM, Widjaja L, Gill PS, Krasnoperov V, Jiang W, Dall’Acqua WF, et al. Framework shuffling of antibodies to reduce immunogenicity and manipulate functional and biophysical properties. Mol Immunol. 2007;44:3049-60. (Purification)
25. Su K, Li X, Edberg JC, Wu J, Ferguson P, Kimberly RP. A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcγRIIb alters receptor expression and associates with autoimmunity. II. Differential binding of GATA4 and Yin-Yang1 transcription factors and correlated receptor expression and function. J Immunol. 2004;172:7192-9. (Stim)

Isotype control 分型對照組 | 分型對照組套組 | 抗體分型ELISA 套組 | anti-rabbit 二級抗體 | anti-mouse二級抗體 |